Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Prostate (Late Stage^), 2015-2019

All Races (includes Hispanic), Male, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 23.1 (23.0, 23.2) N/A 44,049 20.9
Alabama 6 19.1 (18.3, 19.8) 45 (43, 48) 580 15.6
Alaska 6 22.8 (20.4, 25.3) 32 (11, 44) 86 24.0
Arizona 6 17.3 (16.7, 17.8) 49 (47, 50) 761 22.1
Arkansas 6 20.7 (19.7, 21.6) 42 (34, 45) 380 17.2
California 3 23.6 (23.3, 23.9) 27 (23, 31) 4,972 24.6
Colorado 6 23.1 (22.3, 23.9) 30 (22, 36) 701 23.9
Connecticut 3 27.6 (26.6, 28.6) 9 (3, 13) 620 22.1
Delaware 6 21.5 (19.8, 23.2) 38 (26, 45) 134 16.5
District of Columbia 6 28.6 (25.9, 31.4) 5 (1, 23) 87 21.6
Florida 6 18.8 (18.5, 19.1) 46 (44, 48) 2,771 19.2
Georgia 3 23.4 (22.9, 24.0) 28 (22, 34) 1,282 17.4
Hawaii 3 26.9 (25.4, 28.5) 11 (3, 21) 250 27.2
Idaho 3 24.7 (23.3, 26.1) 23 (10, 34) 253 21.1
Illinois 3 26.3 (25.7, 26.8) 12 (9, 18) 1,951 23.1
Indiana 6 23.1 (22.4, 23.8) 29 (24, 36) 907 23.2
Iowa 3 30.4 (29.3, 31.6) 2 (1, 6) 603 25.6
Kansas 6 20.6 (19.6, 21.6) 43 (35, 45) 356 18.2
Kentucky 3 20.7 (19.9, 21.5) 41 (36, 44) 552 18.8
Louisiana 3 28.1 (27.2, 29.0) 7 (3, 12) 764 20.3
Maine 6 24.7 (23.3, 26.2) 22 (11, 33) 249 25.1
Maryland 6 21.8 (21.1, 22.6) 37 (31, 41) 762 16.4
Massachusetts 3 26.1 (25.3, 26.8) 13 (9, 21) 1,087 23.1
Michigan 6 23.1 (22.5, 23.6) 31 (25, 35) 1,490 20.9
Minnesota 6 29.1 (28.3, 30.0) 4 (2, 8) 981 25.4
Mississippi 6 25.4 (24.4, 26.6) 16 (10, 27) 445 18.7
Missouri 6 22.3 (21.6, 23.0) 34 (29, 39) 844 23.1
Montana 6 28.4 (26.7, 30.2) 6 (1, 16) 211 21.3
Nebraska 6 27.6 (26.2, 29.0) 8 (3, 17) 314 21.7
New Hampshire 6 24.7 (23.3, 26.3) 21 (10, 34) 229 20.9
New Jersey 3 22.5 (21.9, 23.1) 33 (28, 38) 1,198 16.0
New Mexico 3 17.9 (16.8, 18.9) 48 (44, 50) 237 21.2
New York 3 25.6 (25.2, 26.0) 15 (11, 21) 2,950 19.4
North Carolina 6 24.0 (23.5, 24.6) 26 (19, 31) 1,445 19.1
North Dakota 6 27.2 (25.0, 29.5) 10 (2, 25) 122 22.3
Ohio 6 24.3 (23.7, 24.8) 24 (18, 29) 1,787 21.5
Oklahoma 6 18.3 (17.5, 19.1) 47 (44, 50) 420 18.3
Oregon 6 25.1 (24.2, 26.0) 19 (11, 27) 666 25.5
Pennsylvania 6 24.2 (23.7, 24.7) 25 (19, 29) 2,037 22.0
Puerto Rico 6 12.8 (12.1, 13.5) N/A 252 8.5
Rhode Island 6 25.0 (23.3, 26.8) 20 (8, 34) 166 21.6
South Carolina 6 20.7 (20.0, 21.5) 39 (36, 44) 665 18.2
South Dakota 6 26.0 (24.1, 28.0) 14 (4, 30) 143 21.5
Tennessee 6 22.2 (21.5, 22.9) 35 (29, 39) 910 18.9
Texas 3 20.7 (20.4, 21.1) 40 (37, 43) 2,865 20.2
Utah 3 25.2 (24.0, 26.5) 18 (9, 29) 341 21.4
Vermont 6 29.1 (26.8, 31.5) 3 (1, 16) 130 28.9
Virginia 6 19.5 (19.0, 20.1) 44 (42, 47) 955 19.1
Washington 5 25.3 (24.6, 26.0) 17 (11, 24) 1,087 24.7
West Virginia 6 16.8 (15.7, 17.8) 50 (47, 50) 213 16.5
Wisconsin 6 30.8 (29.9, 31.6) 1 (1, 4) 1,134 25.3
Wyoming 6 22.0 (19.9, 24.3) 36 (18, 45) 84 19.3
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2022 9:17 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
3 Source: SEER November 2021 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top